Share This

Public company info - Shanghai Pharmaceuticals Holding Co. Ltd. - H Shares , 02607.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Shanghai Pharmaceuticals Holding Co. Ltd. - H Shares, 02607.HK - Cash Flow 2022-12 2021-12 2020-12 2019-12 2018-12 2017-12 2016-12 2015-12 2014-12 2013-12 2012-12 2011-12 2010-12 2009-12 2008-12
Net Cash Flow from Operating Activities 12,342,340 11,300,326 12,694,144 7,427,235 4,304,698 3,391,701 2,782,448 2,060,673 1,829,417 1,421,017 1,490,692 2,044,114 2,099,187 2,217,937 1,359,842
Net Cash Flow from Return on Investments & Servicing of Finance -3,768,833 -3,323,089 -3,454,303 -2,413,714 -2,112,059 -1,353,209 -1,050,259 -1,254,487 -1,107,724 -787,551 -657,864 -541,921 -451,948 -570,002 -551,431
　Interest Received 0 0 0 234,398 201,836 161,207 171,997 139,871 204,882 248,718 319,762 229,514 45,041 56,005 40,250
　Interest Paid 0 0 0 -1,418,907 -1,337,199 -846,295 -556,189 -598,402 -552,450 -410,058 -461,000 -453,733 -231,768 -217,961 -300,338
　Dividend Received 0 0 63,315 366,136 423,392 577,207 490,172 233,604 263,540 247,710 179,609 198,260 219,636 79,532 163,512
　Dividend Paid -3,768,833 -3,323,089 -3,517,618 -1,595,341 -1,400,088 -1,245,328 -1,156,239 -1,029,560 -1,023,696 -873,921 -696,235 -515,962 -484,857 -487,578 -454,855
　Others 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Taxes (Paid) / Refunded -7,598,979 -6,238,999 -5,849,424 -1,639,247 -1,371,420 -904,099 -1,007,778 -851,381 -698,625 -696,285 -659,679 -501,190 -405,738 -292,396 -231,380
Net Cash Flow from Investing Activities -12,473,124 -6,015,576 -1,768,992 -4,950,414 -8,116,132 -2,932,245 -3,379,713 -2,142,517 -2,108,113 -1,140,510 -354,084 -3,988,683 -3,015,011 136,745 -15,879
　Additions to Fixed Assets -2,684,864 -4,118,771 -3,009,971 -2,753,125 -1,943,044 -2,007,272 -2,119,285 -1,581,919 -1,165,804 -887,939 -708,909 -413,536 -551,453 -752,511 -610,765
　Disposal of Fixed Assets 160,338 190,900 383,859 141,904 64,174 119,784 216,190 367,642 151,999 35,833 20,067 41,609 554,308 353,941 504,439
　Increase in Investments -39,768,083 -4,300,863 -6,646,702 -900,476 -5,449,299 -1,154,136 -1,751,105 -720,598 -1,846,573 -589,167 -266,741 -3,894,228 -2,107,180 -316,670 -11,444
　Decrease in Investments 29,493,900 2,649,572 4,283,036 66,201 109,454 317,802 12,396 40,887 770,576 137,172 79,301 33,192 218,776 879,685 151,421
　Net Cash Flow with Related Parties 141,544 169,344 141,546 -226,180 -18,788 -94,847 838,078 55,122 -219,469 -550,976 -171,734 46,316 46,813 611,160 168,336
　Others 184,041 -605,758 3,079,240 -1,278,738 -878,629 -113,576 -575,987 -303,651 201,158 714,567 693,932 197,964 -1,176,275 -638,860 -217,866
Net Cash Flow before Financing Activities -11,498,596 -4,277,339 1,621,426 -1,576,140 -7,294,913 -1,797,852 -2,655,302 -2,187,712 -2,085,045 -1,203,329 -180,935 -2,987,680 -1,773,510 1,492,284 561,152
Net Cash Flow from Financing Activities 15,907,427 4,888,718 2,256,388 688,449 10,263,608 4,406,301 2,359,831 2,264,397 627,334 562,414 -1,095,589 11,612,752 3,042,070 98,438 82,981
　New Loans 48,651,965 37,554,016 36,769,160 40,046,614 63,604,487 26,807,105 19,984,775 20,529,954 14,785,569 11,641,631 8,085,497 11,355,279 6,255,332 5,322,571 5,986,324
　Loans Repayment -59,808,669 -52,214,562 -47,575,480 -38,965,913 -55,843,776 -22,302,488 -18,309,491 -18,367,451 -13,978,766 -10,550,241 -8,897,811 -12,753,308 -5,212,429 -5,808,644 -6,021,337
　Fixed Income/Debt Instruments 14,992,508 18,992,660 12,495,813 0 0 0 0 0 0 0 0 0 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
　Equity Financing 0 0 0 0 2,529,303 0 0 0 0 0 0 12,951,621 1,999,604 0 0
　Net Cash Flow with Related Parties 141,544 169,344 141,546 -226,180 -18,788 -94,847 838,078 55,122 -219,469 -550,976 -171,734 46,316 46,813 611,160 168,336
　Others 11,930,079 387,260 425,349 -166,072 -7,618 -3,469 -153,531 46,772 40,000 22,000 -111,541 12,844 -47,250 -26,649 -50,342
Increase(Decrease) in Cash & Cash Equivalents 4,408,831 611,379 3,877,814 -887,691 2,968,695 2,608,449 -295,471 76,685 -1,457,711 -640,915 -1,276,524 8,625,072 1,268,560 1,590,722 644,133
Cash & Cash Equivalents at Beginning of Year 20,137,500 19,576,445 15,716,258 16,605,555 13,569,414 10,979,744 11,277,855 11,190,420 12,645,367 13,300,901 14,554,709 6,210,449 4,776,503 3,185,370 2,545,972
Net Cash Flow due to Change in Exchange Rate/Others -12,440 -50,323 -17,628 -1,606 67,446 -18,779 -2,640 10,750 2,764 -14,619 22,716 -280,812 -5,490 411 -4,735
Cash & Cash Equivalents at End of Year 24,533,891 20,137,500 19,576,445 15,716,258 16,605,555 13,569,414 10,979,744 11,277,855 11,190,420 12,645,367 13,300,901 14,554,709 6,039,573 4,776,503 3,185,370
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit Thousand Thousand Thousand Thousand
Auditor's Opinion 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.